The WACC of Basilea Pharmaceutica AG (BSLN.SW) is 6.6%.
| Range | Selected | |
| Cost of equity | 5.60% - 8.00% | 6.80% |
| Tax rate | 0.30% - 0.40% | 0.35% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.3% - 7.8% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 1.0% | 1.5% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.91 | 0.99 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.60% | 8.00% |
| Tax rate | 0.30% | 0.40% |
| Debt/Equity ratio | 0.23 | 0.23 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.3% | 7.8% |
| Selected WACC | 6.6% | |